Endocrinology · 2008 · 99 citations · 38 references
Life SciencesEndocrinologyPhysiologyMetabolic PhysiologyMetabolic RegulationSignal TransductionBrain Energy MetabolismCarbohydrate MetabolismDiabetes MellitusGlycemic ControlInsulin ResistanceMetabolic SignalingBasal Energy ExpenditureEnergy Expenditure AlterationGlucagon-like Peptide 1 Receptor AgonismGlucagon-like Peptide 1 SignalingGlucagon-like Peptide-1 Receptor SignalingGlucagon-like PeptidesThermogenesis Suppression
Glucagon-like peptide-1 (GLP-1) is a peptide released by the intestine and the brain. We previously demonstrated that brain GLP-1 increases glucose-dependent hyperinsulinemia and insulin resistance. These two features are major characteristics of the onset of type 2 diabetes. Therefore, we investigated whether blocking brain GLP-1 signaling would prevent high-fat diet (HFD)-induced diabetes in the mouse. Our data show that a 1-month chronic blockage of brain GLP-1 signaling by exendin-9 (Ex9), totally prevented hyperinsulinemia and insulin resistance in HFD mice. Furthermore, food intake was dramatically increased, but body weight gain was unchanged, showing that brain GLP-1 controlled energy expenditure. Thermogenesis, glucose utilization, oxygen consumption, carbon dioxide production, muscle glycolytic respiratory index, UCP2 expression in muscle, and basal ambulatory activity were all increased by the exendin-9 treatment. Thus, we have demonstrated that in response to a HFD, brain GLP-1 signaling induces hyperinsulinemia and insulin resistance and decreases energy expenditure by reducing metabolic thermogenesis and ambulatory activity.
38
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Patrice D. Cani, Jacques Amar, Miguel A. Iglesias et al. · Diabetes · 2007 · 6.4K citations · Full text
Patrice D. Cani, Audrey M. Neyrinck, Francesca Fava et al. · Diabetologia · 2007 · 1.8K citations · Full text
Gerald I. Shulman, Douglas L. Rothman, Thomas Jue et al. · New England Journal of Medicine · 1990 · 1.2K citations · Full text